News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Recce Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Health: Respiri will begin a 4,500-bed trial of its ‘wheezo’ asthma device in India next month
Health & Biotech
Health: Poor pigs and dairy performance offsets feedlot wins at Apiam
Health & Biotech
Marijuana skin cream kills superbugs, says Botanix
Stockhead TV
VIDEO: 90 Seconds With… James Graham, Recce Pharmaceuticals
Health & Biotech
How the biotech community is fighting back against superbugs
Health & Biotech
Check-up: What’s happening with the ASX small cap health stocks?
News
Kick Back: The 10 biggest stories you might have missed on Stockhead this week
Health & Biotech
Why this 29-year-old investor took a six-figure stake in a $17m biotech company
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
US can’t resist Recce’s new antibiotic: A patent’s in the bag and human trials are afoot
Energy
These are the cleantechs you’ll want to kiss after the last quarter
Health & Biotech